Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro

Parasitology International
Luciana Lemos Rangel da SilvaRenato Augusto DaMatta

Abstract

Toxoplasmosis is a widely disseminated disease caused by Toxoplasma gondii, an intracellular protozoan parasite. Standard treatment causes many side effects, such as depletion of bone marrow cells, skin rashes and gastrointestinal implications. Therefore, it is necessary to find chemotherapeutic alternatives for the treatment of this disease. It was shown that a naphthoquinone derivative compound is active against T. gondii, RH strain, with an IC50 around 2.5 μM. Here, three different naphthoquinone derivative compounds with activity against leukemia cells and breast carcinoma cell were tested against T. gondii (RH strain) infected LLC-MK2 cell line. All the compounds were able to inhibit parasite growth in vitro, but one of them showed an IC50 activity below 1 μM after 48 h of treatment. The compounds showed low toxicity to the host cell. In addition, these compounds were able to induce tachyzoite-bradyzoite conversion confirmed by morphological changes, Dolichus biflorus lectin cyst wall labeling and characterization of amylopectin granules in the parasites by electron microscopy analysis using the Thierry technique. Furthermore, the compounds induced alterations on the ultrastructure of the parasite. Taken together, our resu...Continue Reading

References

Aug 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B J Luft, J S Remington
Jul 1, 1990·Mycopathologia·R A BakerS Nemec
Oct 1, 1989·Antimicrobial Agents and Chemotherapy·F Derouin, C Chastang
Jan 1, 1971·Transactions of the Royal Society of Tropical Medicine and Hygiene·W M HutchisonJ C Siim
Dec 27, 1969·British Medical Journal·W M HutchisonK Work
Jul 1, 1996·Phytochemistry·S GafnerK Hostettmann
Oct 12, 2000·International Journal for Parasitology·A F dos SantosA E Sant'Ana
Dec 19, 2000·Infection and Immunity·Y W ZhangL M Weiss
Jul 20, 2002·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A RiffelA Brandelli
Jun 15, 2004·Lancet·J G Montoya, O Liesenfeld
Feb 1, 1993·Parasitology Today·P Ambroise-Thomas, H Pelloux
Jul 19, 2005·Microscopy Research and Technique·Rodrigo Cardoso MagnoMárcia Attias
Dec 26, 2008·Clinical Therapeutics·Barbara IaccheriC Stephen Foster
May 4, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sibylle WinterhalterAntonia Maria Joussen
Apr 26, 2011·Methods in Molecular Biology·Johan van MeerlooJacqueline Cloos
Dec 20, 2011·Veterinary Parasitology·Juliana de Araujo PortesSergio Henrique Seabra
Sep 1, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Helieh S Oz, Thomas Tobin
Sep 25, 2012·Experimental Parasitology·Ronize Andréia FerreiraRicardo Wagner de Almeida Vitor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.